Background: We evaluated the long-term biocompatibility and safety of a new modular posterior chamber intraocular lens (IOL) system in rabbit eyes. Methods: Seven New Zealand rabbits underwent bilateral phacoemulsification with placement of the modular IOL in OD and a control IOL (SA60AT) in OS. Slit-lamp examinations were performed at postoperative weeks 1, 2, 3, 4, 6 and 8 and months 3 and 6. All rabbits were then sacrificed and eyes enucleated. The eyes were examined grossly from the Miyake-Apple view. Selected IOLs were explanted and underwent surface staining for implant cytology. All globes were then sectioned and processed for histopathological examination. Results: The modular IOL remained stable in all seven rabbits through the entire follow-up period. Biocompatibility was better than the control lens at six months postoperatively, on account of less extensive synechiae formation as assessed by slit-lamp examination. At the six-week examination, posterior capsule opacification (PCO) was significantly better in the test group (scored as 1.71 AE 0.8 versus 3.28 AE 0.48 in the control group, p = 0.0008). On gross examination with the Miyake-Apple view, Soemmering's ring formation was significantly better in the test group, (5.14 AE 1.57 versus 10.85 AE 1.95 in the control group, p = 0.002). Conclusion: Previous studies showed that explantation/exchange of the modular system optic was safer and easier than with a standard IOL. The new modular IOL system has demonstrated better long-term biocompatibility compared to the control lens at six months postoperatively in the rabbit model.
Introduction
In 2010, more than 24 million Americans were affected by cataracts. By 2050, this number is expected to double to more than 50 million (Cataracts Defined Tables | National Eye Institute [Internet] . [cited 2017 Mar 24] . Available from: https://nei.nih.gov/eyedata/ cataract/tables). Consequently, there will be increasing demand for cataract surgery. A recent population-based study by Erie et al. (2007) found that the incidence of cataract surgery increased by 500% in women and 467% in men from 1980 to 2004. A similar trend was observed in a subsequent study from 2005 to 2011 (Gollogly et al. 2013) . Although surgical techniques have improved and much work has been performed to refine preoperative intraocular lens (IOL) power calculations, between 0.53% and 1.75% of patients undergoing cataract surgery will ultimately require subsequent IOL exchange (Lyle & Jin 1992; Jin et al. 2005; Jones et al. 2014) . Incorrect IOL power is consistently among the most frequent reasons for IOL explanation in the annual survey of complications associated with foldable IOLs by Mamalis (2000) , Mamalis & Spencer (2001) , Mamalis (2002) , Mamalis et al. (2004 Mamalis et al. ( , 2008 . Considerable efforts to improve the accuracy of preoperative IOL power calculations have been made in the last decade to address this with limited success (Hengerer et al. 2011; Ford et al. 2014) . The increasing number of cataract surgery patients with previous refractive surgery has complicated this issue due to their propensity to cause corneal topographic alterations and reduce the accuracy of preoperative keratometry (Ford et al. 2014) . Additionally, modern cataract surgery patients have less tolerance for imperfect postoperative refractive outcomes and dependence on eyeglasses (Jin et al. 2005; Ford et al. 2014; Jones et al. 2014) . Paediatric patients also represent a challenging population, considering the growth of the eye postoperatively with associated refractive changes (Ford et al. 2014) .
As a result of increasing incidence of cataract surgery and rising patient expectations for perfect refractive outcomes, the need for innovation in postoperative refractive adjustments is greater than ever. One promising new technology that can potentially address this need is the ClarVista HarmoniÒ foldable Modular IOL system (ClarVista Medical, Aliso Viejo, CA, USA), with separate base and optic components allowing for safer and easier postoperative IOL exchange (Guan et al. 2016) . In previous studies performed in our laboratory, we evaluated short-term uveal and capsular biocompatibility of this modular system and the ease of removal/exchange of the optic component in comparison with a standard IOL (MacLean et al. 2015; Guan et al. 2016) . In this study, we evaluate the long-term stability and biocompatibility of the system, through a rabbit implantation protocol defined by the International Organization for Standardization (ISO) 11979-5, Annex G:2006(E).
Materials and Methods
Seven New Zealand White rabbits were acquired from an approved vendor in accordance with Animal Welfare Act requirements. This study was conducted in accordance with the requirements of the Food and Drug Administration (FDA) Good Laboratory Practices (GLP) regulations (Final rule 21 CRF part 58) and International Organization for Standardization/American National Standards Institute (ISO/ANSI) standards. All rabbits were treated in accordance with Association for Research in Vision and Ophthalmology (ARVO) guidelines, the Animal Welfare Act regulations and the 'Guide for the Care and Use of Laboratory Animals'. Each animal underwent bilateral phacoemulsification by the same surgeon (N.M.) with implantation of the test modular IOL system in the right eye and the control IOL in the left eye. The test IOL was the ClarVista HarmoniÒ Modular IOL (ClarVista Medical, Aliso Viejo, CA, USA) consisting of a modular posterior chamber and hydrophobic acrylic IOL system with two separate components: a base and an optic. The overall diameter of the base from haptic tip to tip is 13.0 mm; the diameter of the base body is 7.8 mm. The base and haptics have square edges on the anterior and posterior surfaces. The diameter of the optic is 5.8 mm. The optics had a dioptric power ranging from +19 to +21 D. The control IOL was the AcrySofÒ model SA60AT (Alcon, Ft. Worth, TX, USA) which also had a dioptric power ranging from +19 to +21 D (Fig. 1) .
Preoperative care, surgical anaesthesia and bilateral phacoemulsification with IOL implantation were performed as detailed in previous studies (Kavoussi et al. 2011; Leishman et al. 2012; Ollerton et al. 2012; Floyd et al. 2013; MacLean et al. 2015; Guan et al. 2016) . Using aseptic technique and a surgical microscope, a fornixbased conjunctival flap was fashioned. A corneal-scleral incision was then made using a crescent blade, and the anterior chamber was entered with a 3 mm keratome, followed by injection of an ophthalmic viscosurgical device (OVD) material (Amvisc Plus, Bausch & Lomb, Rochester, NY, USA). A capsulorhexis forceps was used to create a continuous curvilinear capsulotomy, with a diameter of approximately 5-5.5 mm. After hydrodissection, the phaco handpiece (Alcon Infiniti) was inserted into the posterior chamber for removal of lens nucleus and cortical material. One millilitre of epinephrine 1:1000 and 0.5 ml of heparin (10 000 USP units/ ml) were added to each 500 ml of irrigation solution to facilitate pupil dilation and control inflammation. The endocapsular technique was used with the phacoemulsification to take place entirely within the capsular bag. Any residual cortex was then removed with an automated irrigation/aspiration handpiece. After removal of the lens, the same OVD was used to inflate the capsular bag, and the IOLs were then inserted into the capsular bag using the manufacturer's recommended injector systems. In the test eyes, the base component of the lens was injected into the eye using the Accuject 2.2-HT injection system (Medicel AG, Altenrhein, Switzerland) and fixated in the capsular bag. The optic was then injected with the same system and securely attached to the base component by engaging the fixation features with a surgical hook. The Monarch System (Alcon) was used to inject the control lens. Wound closure was achieved with 10.0 monofilament nylon suture after removal of OVD material using the irrigation/aspiration handpiece.
Combination antibiotics/steroid ointment (neomycin and polymyxin B sulphates, and dexamethasone) was applied to each eye immediately following surgery and continued four times daily for a total of one week. In the second postoperative week, each animal received topical prednisolone acetate drops four times daily in each eye for a total of one week. Gross examinations were performed on postoperative day one. Slit-lamp examinations were then performed at postoperative weeks 1, 2, 3, 4, 6 and 8 and months 3 and 6. A standard scoring method in specific categories was used at each examination, including assessment of corneal oedema, and the presence of cell and flare within the anterior chamber. Anterior capsule opacification (ACO) and posterior capsule opacification (PCO) development were assessed and scored from 0 to 4. Representative clinical colour photographs of the eyes were obtained with a digital camera coupled to the slit lamp at each examination. After a follow-up of six months, the animals were anesthetized using a 1-2 ml intramuscular injection of a 7:1 mixture of ketamine hydrochloride and xylazine, and then humanely euthanized with an intravenous injection of pentobarbital sodium/phenytoin sodium. Their globes were enucleated, rinsed in water and placed in 10% neutral buffered formalin. The globes were bisected coronally just anterior to the equator. Gross examination and photographs from the posterior aspect (MiyakeApple view) were performed assessing for IOL fixation and centration, as well as capsular bag opacification as detailed in previous studies (Kavoussi et al. 2011; Leishman et al. 2012; Ollerton et al. 2012; Floyd et al. 2013; MacLean et al. 2015; Guan et al. 2016) . Briefly, the extent and severity of ACO and PCO were scored as follows:
(1) ACO was scored from 0 to 4, at the area of anterior capsule contacting the anterior optic surface.
(2) Central PCO (related to the central 3 mm behind the optic) was scored from 0 to 4. (3) Peripheral PCO (related to the peripheral area behind optic) was scored from 0 to 4. (4) Soemmering's ring formation (related to proliferative material within the equatorial region of the capsular bag, outside of the optic) had a score of intensity from 0 to 4, and a score of area, related to the number of quadrants involving the highest intensity.
The test and control IOLs were then carefully removed from the capsular bag. Selected IOLs from each group (lenses with the least amount of proliferative material attached to their surfaces, as excessive material precludes appropriate evaluation) were carefully evaluated following removal from the globe for surface cellular reactions, cell debris and fibrinous deposits. The implant cytology staining was performed as follows: rinsing in distilled water, staining with hematoxylin for 2 min, rinsing in distilled water, staining with eosin for 2 min and final rinsing in distilled water. All globes were then sectioned, and the anterior segments including the capsular bags as well as posterior segments processed for standard light microscopy and stained with hematoxylin and eosin (H & E). Histopathologic examination was then performed assessing for intraocular inflammation, toxicity, as well as ACO and PCO to determine biocompatibility as detailed in previous studies (Kavoussi et al. 2011; Leishman et al. 2012; Ollerton et al. 2012; Floyd et al. 2013; MacLean et al. 2015; Guan et al. 2016) .
Results
In general, injection of the base and optic components of the test system and the control IOLs were found to be well controlled. The attachment of the optic component of the test IOL to the base component was uneventful. Both the test and control IOLs were fully injected within the capsular bag in most cases, while in others a small manoeuver with a collar button hook was necessary to complete in-the-bag fixation. There were no surgical complications requiring exclusion of any rabbit from the study.
Slit-Lamp examinations
At the Week 1 examination, all eyes in the study exhibited a mild inflammatory reaction composed of aqueous cells, as well as fibrin formation in front of the lens or at the capsulorhexis edge. Superior corneal oedema was observed in two test eyes. The inflammatory reaction was practically resolved by the Week 2 examination, although few eyes in both test and control groups still had some residual fibrin formation. One of the test eyes still had a mild superior corneal oedema. Mild PCO started to be observed in most eyes at Week 2, with progression thereafter. At the Week 4 examination, it was noted that the optic of one of the test eyes appeared tilted. At four weeks, PCO was scored 1.28 AE 1.03 in the test group and 2.07 AE 1.01 in the control group (paired two samples for means t-test; two-tailed p = 0.21). At six weeks, PCO was scored 1.71 AE 0.80 in the test group and 3.28 AE 0.48 in the control group (paired two samples for means t-test; two-tailed p = 0.0008) (Fig. 2) .
At eight weeks, the majority of eyes in both groups had posterior synechia formation between the iris and proliferative material/pearls in front of the lens. Growth of proliferative material/ pearls between the two parts of the test lens was not observed. Some eyes in both groups had giant cell deposits on the IOL surface. From eight weeks on, PCO was found to be severe in both groups, as expected in long-term studies in the rabbit model. Mild degrees of ACO were observed in this study (scores 0.5 or 1) in both groups of eyes. This parameter became increasingly difficult to assess towards the end of the study, because of posterior synechia formation and poor pupillary dilation. At the six-month examination, all eyes had posterior synechia formation, which appeared more severe in the control group. This parameter was scored 1.85 AE 0.89 in the test group and 3.0 AE 0.81 in the control group (paired two samples for means ttest; two-tailed p = 0.004). All test IOLs appeared centred, while 3 control IOLs appeared slightly decentred (although this was sometimes difficult to assess due to deformation of the pupil related to synechia formation). Six control IOLs had partial pupillary optic capture. The optic of one test IOL appeared slightly tilted (Fig. 3) .
Gross examination
Gross examination of the anterior segments from the posterior view showed that all of the IOLs were symmetrically fixated within the capsular bag. The base of the test IOL was stable and centred in all eyes, while at least 4 control IOLs exhibited partial pupillary optic capture. One of the control IOLs was also decentred in relation to the ciliary processes. The optic of one test IOLs had the plate haptic side behind the base, which caused the optic to be slightly tilted. Proliferative material entered that side to grow in front of the optic of the IOL. Central PCO was scored 3.28 AE 0.75 in the test group and 3.85 AE 0.37 in the control group (paired two samples for means t-test; two-tailed p = 0.172). Peripheral PCO was scored 3.42 AE 0.53 in the test group and 3.85 AE 0.37 in the control group (paired two samples for means t-test; two-tailed p = 0.199). Soemmering's ring formation was scored as 5.14 AE 1.57 in the test group and 10.85 AE 1.95 in the control group (paired two samples for means t-test; two-tailed p = 0.002) (Fig. 4) .
Implant cytology
Two test IOLs and two control IOLs with the least amount of proliferative material were selected for IOL surface evaluation. All IOLs appeared to have a mixture of macrophages, epithelioid cells, giant cells and spindle-shaped cells attached to their surface (Fig. 5) . Complete assessment in each case was difficult due to the presence of proliferative material on the posterior surface of all IOLs.
Histopathology
Evaluation of multiple sections of the anterior segment of each eye showed posterior synechia formation in both control and study eyes. The posterior synechiae were more prominent in the control eyes in areas of pupillary optic capture. In addition, the control eyes showed extension of iris covering the pupillary space on the anterior IOL surface in several of the eyes. There was no sign of untoward inflammation or (A) (B) Fig. 3 . Slit-lamp photographs of both eyes of the same rabbit taken at six months postoperatively, showing PCO formation in the test (A) and control (B) eyes. There is also a partial pupillary optical capture of the optic in the control eye (B). PCO = posterior capsule opacification. toxicity in the anterior or posterior segments of any study or control eye.
Discussion
As the number of Americans affected by cataracts doubles in the next 30 years and expectations for flawless refractive outcomes following cataract surgery continue to rise, the demand for postoperative refractive adjustments will likely also increase (Jin et al. 2005; Ford et al. 2014; Jones et al. 2014) . A recent study by Jones et al. found that an increasing number of IOL exchanges are being performed for patient dissatisfaction [undesired visual acuity (VA) with low residual refractive error, dysphotopsias or diplopia]: 21% in their 2014 article versus 7% in their 2005 article (Jones et al. 2014) . Of these patients, 42% had undesired VA without photic symptoms (Jones et al. 2014) . Currently, refractive outcomes following cataract surgery still leave much to be desired. In contrast to laser-assisted in situ keratomileusis (LASIK) in which 97% of surgeries achieve refractive outcomes within AE0.5 D of target (Shaheen et al. 2013) , a large case series of 1676 cataract operations by Murphy et al. showed that only 72.3% of eyes were within AE1 D of the target refraction (Murphy et al. 2002) . Another study found that only 55% of eyes achieved emmetropia after cataract surgery (defined as spherical equivalent of AE0.5 D and astigmatism of AE1.0 D) (Behndig et al. 2012 ). Additionally, incorrect IOL power remains one of the most common indications for IOL exchange, resulting in 23% of the IOL exchanges in the Jones et al. (2014) study.
Current mainstream methods for correcting unanticipated refractive error following cataract surgery are limited to IOL exchange, laser refractive surgery and piggyback IOL placement (Jin et al. 2007 ). These methods have all been shown to be effective for postoperative refractive correction in previous studies; however, they are not without complications (Jin et al. 2007 ). IOL exchange is technically challenging because of strong adherence of the capsular bag to the IOL, particularly in the late postoperative period. Perioperative complications in order of decreasing frequency include vitreous loss, posterior capsule rupture and zonular dehiscence (Leysen et al. 2009 ). Post-cataract surgery, LASIK can interfere with wound healing and IOL stability (Ayala et al. 2001 ). Complications from piggyback IOL placement include secondary pigmentary glaucoma, pigment dispersion syndrome, iris chafing, pupillary optic capture, postoperative elevation of intraocular pressure (IOP) and interlenticular opacification (Jin et al. 2007 ). Other novel methods under development for postoperative refractive adjustment include mechanically adjustable IOLs, repeatedly adjustable IOLs, magnetically adjustable IOLs, liquid crystal intraocular adaptive lenses, postoperative adjustment with femtosecond laser or two-photon chemistry and ultraviolet (UV) lightadjustable lenses (Ford et al. 2014) . Each of these new technologies has advantages and disadvantages, but none are currently commercially available in the USA. The UV lightadjustable lenses are currently undergoing phase 3 clinical trials and are the closest to commercial availability. While the UV light-adjustable lens is a promising technology allowing for multiple postoperative adjustments, patients are required to wear UV blocking glasses until the desired IOL power is locked-in as direct exposure to ambient light can cause problematic refractive surprises (Ford et al. 2014) . Additionally, once the lock-in procedure is complete, the IOL power can no longer be adjusted (Ford et al. 2014) .
Optic exchange with the ClarVista HarmoniÒ Modular IOL system represents an alternative to these methods for postoperative refractive adjustments following cataract surgery. A previous study in our laboratory by Guan et al. found optic exchange in the ClarVista Harmoni Ò Modular system to be easier than traditional IOL exchange with the control Alcon AcrySof SA60AT in the rabbit model at two and six weeks postoperatively (Guan et al. 2016) . More manipulation of the capsular bag with subsequent increased stress on the zonules was required to disengage the haptics of the control lens as compared to the test lens, especially at the postoperative Week 6 exchange procedure given the accelerated proliferative capacity of rabbits (six weeks in the rabbit model correspond to roughly two years in humans) (Guan et al. 2016 ). This finding is particularly relevant to paediatric cataract surgery as multiple IOL exchanges are often required many years after the original procedure due to unpredictable degrees of myopic shift (Kraus et al. 2016) . In addition to affording easier postoperative IOL exchange, the ClarVista Harmoni Ò Modular system was shown in a previous ex vivo study by SooHoo et al. (2016) to be more stable in the capsular bag under changes in IOP than a standard single-piece hydrophobic acrylic IOL. This could improve IOL power selection by allowing for precise intra-operative measurement of effective lens position (ELP) after implantation of the base unit with ultrasound or optical coherence tomography with subsequent calculation of IOL power and implantation of the correct optic unit. As errors in predicted postoperative anterior chamber depth (used as a surrogate for ELP) account for the largest percentage of incorrect IOL power calculations (SooHoo et al. 2016 ), a modular IOL system like this with superior capsular stability that also allows for intra-operative optic power selection after direct ELP calculation could significantly reduce incorrect IOL power calculations. This is the first long-term in vivo study of the ClarVista HarmoniÒ Modular IOL system in the rabbit model and was conducted in accordance with FDA GLP regulations and international standards. The modular lens system demonstrated better longterm biocompatibility compared to the control lens at six months postoperatively. Posterior capsule opacification (PCO) formation was significantly less in the modular system at six weeks than the control lens, but both groups showed significant PCO formation after eight weeks as expected in longterm rabbit studies given their accelerated proliferative capacity as demonstrated in previous studies (Kavoussi et al. 2011; Leishman et al. 2012; Ollerton et al. 2012; Floyd et al. 2013; MacLean et al. 2015; Guan et al. 2016) . It is interesting to note, however, that Soemmering's ring formation was significantly less in the modular system at the conclusion of the study than in the control IOL. Additionally, in spite of the accelerated proliferation of cortical material in the rabbit model, all of the modular IOL systems were found to be stable and well centred at the conclusion of the study, while more than half of the control lenses demonstrated partial pupillary optic capture. The superior stability of the modular system may be due to design features including a stable haptic-base junction intended to prevent motion in the anterior-posterior plane and a base unit designed to occupy additional space in the peripheral capsular bag (SooHoo et al. 2016) .
These results are consistent with the previous short-term in vivo rabbit study by MacLean et al. (2015) which demonstrated significantly less PCO formation in the modular IOL system at six weeks and similar or better biocompatibility compared to the control lens.
In conclusion, this study confirms the biocompatibility and stability of the ClarVista Harmoni Ò Modular IOL system in the rabbit model. The potential advantages of this modular lens system warrant human clinical trials. Besides those already mentioned in this text, other benefits of the modular system include addressing dissatisfied multifocal patients, adjusting toric placement due to error or cornea change and allowing access to new optical technology yet to be developed. At the time of this publication, phase 2-4 clinical trials are currently underway in various non-US locations, with planning active for US phase 3 studies.
